[CBAY] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[CBAY] CymaBay Therapeutics, Inc.
Announcement Date
28-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- 11.37%
Quarter Report
CBAY's Result
CBAY's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 31,073 0 0 0 0 0 10,000 20.78%
PBT -105,370 -106,001 -89,998 -50,986 -102,808 -72,548 -27,557 25.03%
Tax 0 12,890 2,583 -2,321 -572 293 -4,693 -
NP -105,370 -118,891 -92,581 -48,665 -102,236 -72,548 -27,557 25.03%
Tax Rate - - - - - - - -
Total Cost 136,443 118,891 92,581 48,665 102,236 72,548 37,557 23.97%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -339.10 0.00 0.00 0.00 0.00 0.00 -275.57 3.51%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.99 -1.35 -1.30 -0.71 -1.53 -1.25 -0.79 3.83%
EPS Diluted -0.99 -1.35 -1.30 -0.71 -1.53 -1.25 -0.79 3.83%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.